Home > Personal Investment Vitae
Location: United States
Gender: Female
Asset investment style: Quantitative fundamental analysis
Market capitalization:
$8,344,547talentsVirtual portfolio value:
$5,155,429talentsNet overall return per annum:
18.87%AYA current rank order:
#13Asset investment philosophy:
Daisy Harvey trades U.S. stocks with the top #76 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 56,283 | +681.13% | $203,182 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 24,133 | +2,108.33% | $183,169 |
| LGVN | Longeveron Inc. Class A Common Stock | $3.45 | $26.25 | 2,347 | +660.87% | $53,512 |
| AXSM | Axsome Therapeutics Inc. Common Stock | $4.60 | $31.75 | 1,335 | +590.22% | $36,245 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 881 | +589.24% | $36,183 |
| SQ | Block Inc. Class A Common Stock | $14.50 | $99.54 | 423 | +586.48% | $35,972 |
| FIVN | Five9 Inc. Common Stock | $16.31 | $110.10 | 376 | +575.05% | $35,265 |
| TRNS | Transcat Inc. Common Stock | $11.35 | $73.00 | 541 | +543.17% | $33,353 |
| GLOB | Globant S.A. Common Shares | $34.57 | $215.99 | 177 | +524.79% | $32,111 |
| HZNP | Horizon Therapeutics Public Limited Company Ordinary Shares | $16.41 | $98.56 | 374 | +500.61% | $30,724 |
| Sum | $679,716 |
Top 10 current stock portfolio positions as of June 2026Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| NVCT | Nuvectis Pharma Inc. Common Stock | $27.19 | 2,380 | $64,712 |
| QURE | uniQure N.V. Ordinary Shares | $47.51 | 813 | $38,625 |
| MBX | MBX Biosciences Inc. Common Stock | $52.31 | 737 | $38,552 |
| AMAT | Applied Materials Inc. Common Stock | $626.84 | 51 | $31,968 |
| TECH | Bio-Techne Corp Common Stock | $71.00 | 449 | $31,879 |
| HURC | Hurco Companies Inc. Common Stock | $22.53 | 1,351 | $30,438 |
| LGND | Ligand Pharmaceuticals Incorporated Common Stock | $303.59 | 100 | $30,359 |
| MGNI | Magnite Inc. Common Stock | $18.73 | 1,619 | $30,323 |
| HIMS | Hims & Hers Health Inc. Class A Common Stock | $33.94 | 887 | $30,104 |
| WRLD | World Acceptance Corporation Common Stock | $213.77 | 140 | $29,927 |
| Sum | $356,887 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Chanel Holden | |||
| @Andy Yeh Alpha | |||
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
| @TechBull22 | @Ru-Ting Yeh | @Syl_will | @Najam |
2017-08-19 14:43:00 Saturday ET
In a recent tweet, President Donald Trump criticizes Amazon over taxes and jobs. Without providing specific evidence, Trump accuses of the e-commerce retail
2024-03-26 09:30:00 Tuesday ET
Stock Synopsis: ESG value and momentum stock market portfolio strategies Since 2013, we have been delving into the broad topics of ESG (Environmental, So
2025-06-13 08:23:00 Friday ET
What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo
2018-03-15 07:41:00 Thursday ET
The Trump administration's $1.5 trillion hefty tax cuts and $1 trillion infrastructure expenditures may speed up the Federal Reserve interest rate hike
2023-10-14 10:32:00 Saturday ET
Jonathan Baker frames the current debate over antitrust merger review and enforcement in America. Jonathan Baker (2019) The antitrust paradi
2019-09-03 14:29:00 Tuesday ET
Due to U.S. tariffs and other cloudy causes of economic policy uncertainty, Apple, Nintendo, and Samsung start to consider making tech products in Vietnam i